Development and characterisation of a novel and rapid lung eosinophil influx model in the rat

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 4, 2008, Pages 648-656

  Werner Klein, Melanie ^a   Göggel, Rolf ^a   Westhof, Andreas ^a   Erb, Klaus J ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Animal model; Asthma; Eosinophils; Inflammation; Rat; Steroids; Therapeutics

Indexed keywords

BUDESONIDE; CROMOGLYCATE DISODIUM; CYTOKINE; EOSINOPHIL PEROXIDASE; EPINASTINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 4; INTERLEUKIN 5; KETOTIFEN; METHACHOLINE; METHYLPREDNISOLONE SODIUM SUCCINATE; MONOCYTE CHEMOTACTIC PROTEIN; MONTELUKAST; OVALBUMIN; PREDNISOLONE; ROFLUMILAST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BROWN NORWAY RAT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EOSINOPHILIA; GOBLET CELL; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY TRACT INFLAMMATION;

ALUM COMPOUNDS; AMINOPYRIDINES; ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BENZAMIDES; BRONCHOALVEOLAR LAVAGE FLUID; BUDESONIDE; CYCLOPROPANES; DIBENZAZEPINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; HISTAMINE H1 ANTAGONISTS; IMIDAZOLES; KETOTIFEN; LUNG; MICE; MICE, INBRED BALB C; OVALBUMIN; PHOSPHODIESTERASE INHIBITORS; PREDNISOLONE; RATS; RATS, INBRED BN;

EID: 47249096996     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2008.03.002     Document Type: Article

References (38)

1. Gleich G.J. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 105 (2000) 651-663
2. Woodruff P.G., Khashayar R., Lazarus S.C., Janson S., Avila P., Boushey H.A., et al. Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol 108 (2001) 753-758
3. Green R.H., Brightling C.E., McKenna S., Hargadon B., Parker D., Bradding P., et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360 (2002) 1715-1721
4. Kingham P.J., Costello R.W., and McLean W.G. Eosinophil and airway nerve interactions. Pulm Pharmacol Ther 16 (2003) 9-13
5. Foster P.S., Hogan S.P., Ramsay A.J., Matthaei K.I., and Young I.G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183 (1996) 195-201
6. Lee J.J., Dimina D., Macias M.P., Ochkur S.I., McGarry M.P., O'Neill K.R., et al. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305 (2004) 1773-1776
7. Cho J.Y., Miller M., Baek K.J., Han J.W., Nayar J., Lee S.Y., et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest 113 (2004) 551-560
8. Humbles A.A., Lloyd C.M., McMillan S.J., Friend D.S., Xanthou G., McKenna E.E., et al. A critical role for eosinophils in allergic airways remodeling. Science 305 (2004) 1776-1779
9. Gharaee-Kermani M., and Phan S.H. The role of eosinophils in pulmonary fibrosis (review). Int J Mol Med 1 (1998) 43-53
10. Levi-Schaffer F., Garbuzenko E., Rubin A., Reich R., Pickholz D., Gillery P., et al. Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta). Proc Natl Acad Sci USA 96 (1999) 9660-9665
11. Montesano R., and Orci L. Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. Proc Natl Acad Sci USA 85 (1988) 4894-4897
12. Phipps S., Ying S., Wangoo A., Ong Y.E., Levi-Schaffer F., and Kay A.B. The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J Immunol 169 (2002) 4604-4612
13. Wenzel S.E., Schwartz L.B., Langmack E.L., Halliday J.L., Trudeau J.B., Gibbs R.L., et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 160 (1999) 1001-1008
14. Flood-Page P., Menzies-Gow A., Phipps S., Ying S., Wangoo A., Ludwig M.S., et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 112 (2003) 1029-1036
15. Epstein M.M. Do mouse models of allergic asthma mimic clinical disease?. Int Arch Allergy Immunol 133 (2004) 84-100
16. Haczku A., Moqbel R., Elwood W., Sun J., Kay A.B., Barnes P.J., et al. Effects of prolonged repeated exposure to ovalbumin in sensitized brown Norway rats. Am J Respir Crit Care Med 150 (1994) 23-27
17. Schneider T., van V.D., Moqbel R., and Issekutz A.C. Kinetics and quantitation of eosinophil and neutrophil recruitment to allergic lung inflammation in a brown Norway rat model. Am J Respir Cell Mol Biol 17 (1997) 702-712
18. Underwood S.L., Haddad E., Birrell M.A., McCluskie K., Pecoraro M., Dabrowski D., et al. Functional characterization and biomarker identification in the brown Norway model of allergic airway inflammation. Br J Pharmacol 137 (2002) 263-275
19. Eidelman D.H., Bellofiore S., and Martin J.G. Late airway responses to antigen challenge in sensitized inbred rats. Am Rev Respir Dis 137 (1988) 1033-1037
20. Eynott P.R., Salmon M., Huang T.J., Oates T., Nicklin P.L., and Chung K.F. Effects of cyclosporin A and a rapamycin derivative (SAR943) on chronic allergic inflammation in sensitized rats. Immunology 109 (2003) 461-467
21. Dong W., Selgrade M.K., and Gilmour M.I. Systemic administration of Bordetella pertussis enhances pulmonary sensitization to house dust mite in juvenile rats. Toxicol Sci 72 (2003) 113-121
22. Trujillo-Vargas C.M., Werner-Klein M., Wohlleben G., Polte T., Hansen G., Ehlers S., et al. Helminth-derived products inhibit the development of allergic responses in mice. Am J Respir Crit Care Med 175 (2007) 336-344
23. Hylkema M.N., Hoekstra M.O., Luinge M., and Timens W. The strength of the OVA-induced airway inflammation in rats is strain dependent. Clin Exp Immunol 129 (2002) 390-396
24. Singh P., Daniels M., Winsett D.W., Richards J., Doerfler D., Hatch G., et al. Phenotypic comparison of allergic airway responses to house dust mite in three rat strains. Am J Physiol Lung Cell Mol Physiol 284 (2003) L588-L598
25. Renzi P.M., Olivenstein R., and Martin J.G. Effect of dexamethasone on airway inflammation and responsiveness after antigen challenge of the rat. Am Rev Respir Dis 148 (1993) 932-939
26. Elwood W., Lotvall J.O., Barnes P.J., and Chung K.F. Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitized brown-Norway rats. J Allergy Clin Immunol 88 (1991) 951-960
27. Haczku A., Chung K.F., Sun J., Barnes P.J., Kay A.B., and Moqbel R. Airway hyperresponsiveness, elevation of serum-specific IgE and activation of T cells following allergen exposure in sensitized Brown-Norway rats. Immunology 85 (1995) 598-603
28. Leung S.Y., Eynott P., Nath P., and Chung K.F. Effects of ciclesonide and fluticasone propionate on allergen-induced airway inflammation and remodeling features. J Allergy Clin Immunol 115 (2005) 989-996
29. Schuster M., Tschernig T., Krug N., and Pabst R. Lymphocytes migrate from the blood into the bronchoalveolar lavage and lung parenchyma in the asthma model of the brown Norway rat. Am J Respir Crit Care Med 161 (2000) 558-566
30. Rothenberg M.E., and Hogan S.P. The eosinophil. Annu Rev Immunol 24 (2006) 147-174
31. Taube C., Nick J.A., Siegmund B., Duez C., Takeda K., Rha Y.H., et al. Inhibition of early airway neutrophilia does not affect development of airway hyperresponsiveness. Am J Respir Cell Mol Biol 30 (2004) 837-843
32. Taube C., Dakhama A., Rha Y.H., Takeda K., Joetham A., Park J.W., et al. Transient neutrophil infiltration after allergen challenge is dependent on specific antibodies and Fc gamma III receptors. J Immunol 170 (2003) 4301-4309
33. GINA Report (Global Strategy for Asthma Management and Prevention). 〈www.ginasthma.com〉, 2007.
34. Tasaka K. Epinastine: an update of its pharmacology, metabolism, clinical efficacy and tolerability in the treatment of allergic diseases. Drugs Today 36 (2000) 735-757
35. Meade C.J. The mechanism by which epinastine stops an adenosine analog from contracting BDE rat airways. Am J Respir Crit Care Med 157 (1998) 522-530
36. Szefler S.J., and Nelson H.S. Alternative agents for anti-inflammatory treatment of asthma. J Allergy Clin Immunol 102 (1998) S23-S35
37. Christie P. Roflumilast: a selective phosphodiesterase 4 inhibitor. Drugs Today 41 (2005) 667-675
38. Fan C.K. Phosphodiesterase inhibitors in airways disease. Eur J Pharmacol 533 (2006) 110-117